Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001454982-11-000008)

Filing Details

Accession Number:: 0001454982-11-000008
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-01-18 12:00:00
Reporting Period:: 2011-01-18

Filing Date:: 2011-01-18
Accepted Time:: 2011-01-18 18:38:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
881464	Amylin Pharmaceuticals Inc	AMLN	Pharmaceutical Preparations (2834)	330266089

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1236394	G Orville Kolterman	9360 Towne Centre Dr San Diego CA 92121	Svp, Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-01-18	2,500	$11.13	154,139	No	4	M	Direct
Common Stock	Disposition	2011-01-18	2,500	$15.00	151,639	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2011-01-18	2,500	$15.00	2,500	$11.13

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
7,850		2011-03-08	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,815	Indirect	by ESOP

Footnotes

The sale was affected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
25% of shares vested one year from date of grant and the remainder vested monthly over the next three years becoming fully vested four years from date of grant.